ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.22
-0.45%
Dow Jones
40,211.72
0.53%
Gold vs US Dollar
2,435.23
0.54%
Brent Oil
83.565
-0.92%
Bitcoin
62,650.15
-3.39%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. RayzeBio Inc (RYZB)

  7. RayzeBio Inc (RYZB) News

RayzeBio (RYZB)

RayzeBio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RYZB
DateTimeSourceHeadlineSymbolCompany
07/03/202421:07Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:RYZBRayzeBio Inc
27/02/202421:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYZBRayzeBio Inc
27/02/202421:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYZBRayzeBio Inc
26/02/202414:20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RYZBRayzeBio Inc
26/02/202414:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYZBRayzeBio Inc
23/02/202412:53Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RYZBRayzeBio Inc
23/02/202411:59Business WireBristol Myers Squibb Announces Expiration of RayzeBio Tender OfferNASDAQ:RYZBRayzeBio Inc
14/02/202414:19Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RYZBRayzeBio Inc
12/02/202413:54Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RYZBRayzeBio Inc
12/02/202411:59Business WireBristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting PeriodNASDAQ:RYZBRayzeBio Inc
06/02/202423:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYZBRayzeBio Inc
25/01/202413:53Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:RYZBRayzeBio Inc
08/01/202415:06PR Newswire (US)Kuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to Contact Law FirmNASDAQ:RYZBRayzeBio Inc
27/12/202321:15Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:RYZBRayzeBio Inc
26/12/202322:08Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:RYZBRayzeBio Inc
26/12/202315:28Dow Jones NewsTrending: Bristol Myers Squibb to Buy RayzeBioNASDAQ:RYZBRayzeBio Inc
26/12/202313:32Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:RYZBRayzeBio Inc
26/12/202313:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYZBRayzeBio Inc
26/12/202313:04Dow Jones NewsRayzeBio Shares Soar Premarket on Takeover by Bristol MyersNASDAQ:RYZBRayzeBio Inc
26/12/202312:46Dow Jones NewsBristol Myers Squibb to Buy RayzeBio for $4.1 BillionNASDAQ:RYZBRayzeBio Inc
26/12/202312:13GlobeNewswire Inc.Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBioNASDAQ:RYZBRayzeBio Inc
26/12/202311:59Business Wire Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBioNASDAQ:RYZBRayzeBio Inc
17/11/202323:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYZBRayzeBio Inc
17/11/202323:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYZBRayzeBio Inc
13/11/202321:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RYZBRayzeBio Inc
13/11/202321:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYZBRayzeBio Inc
13/11/202321:01GlobeNewswire Inc.RayzeBio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:RYZBRayzeBio Inc
06/11/202321:05GlobeNewswire Inc.RayzeBio to Participate in Upcoming Investor Conferences in November 2023NASDAQ:RYZBRayzeBio Inc
01/11/202313:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYZBRayzeBio Inc
01/11/202310:00GlobeNewswire Inc.RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of DirectorsNASDAQ:RYZBRayzeBio Inc
 Showing the most relevant articles for your search:NASDAQ:RYZB

Your Recent History

LSE
CPX
Cap-xx
LSE
GDR
Genedrive
LSE
PRU
Prudential
LSE
OCDO
Ocado
LSE
ITM
Itm Power
LSE
ENET
Ethernity Networks
LSE
GWMO
Great Western Mining
LSE
SCLP
Scancell
LSE
AAZ
Anglo Asian Mining
LSE
BOO
Boohoo
LSE
SYME
Supply@me Capital
LSE
VAST
Vast Resources
LSE
BARC
Barclays
LSE
CGH
Chaarat Gold
LSE
ZED
Zenova
LSE
VANQ
Vanquis Banking
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved